Literature DB >> 20236059

Fullerenes: from carbon to nanomedicine.

Pooja Chawla1, Viney Chawla, Radhika Maheshwari, Shubhini A Saraf, Shailendra K Saraf.   

Abstract

Fullerenes, the third carbon allotrope, have emerged as agents which could revolutionize the treatment of many diseases. Fullerenes possess different biological applications like neuroprotective agents, antioxidants, anti-HIV activity, enzyme inhibition, antiapoptotic activity and the list is ever increasing. Moreover, they are being utilized as drug carrier systems and also for many non-biological applications like superconductors, catalysis and so on. Their size has made them promising agents for nanotechnology. This article aims at outlining the chemistry, properties and non-biological applications of fullerenes and their evolution to biological applications, thereby traversing their evolution from simple carbon allotropes to present day nano-medicinal agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236059     DOI: 10.2174/138955710791572497

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  8 in total

1.  Metallofullerene-based nanoplatform for brain tumor brachytherapy and longitudinal imaging in a murine orthotopic xenograft model.

Authors:  Michael D Shultz; John D Wilson; Christine E Fuller; Jianyuan Zhang; Harry C Dorn; Panos P Fatouros
Journal:  Radiology       Date:  2011-08-03       Impact factor: 11.105

2.  Metallofullerene-nanoplatform-delivered interstitial brachytherapy improved survival in a murine model of glioblastoma multiforme.

Authors:  John D Wilson; William C Broaddus; Harry C Dorn; Panos P Fatouros; Charles E Chalfant; Michael D Shultz
Journal:  Bioconjug Chem       Date:  2012-08-21       Impact factor: 4.774

3.  Nanotechnology for photodynamic therapy: a perspective from the Laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School.

Authors:  Michael R Hamblin; Long Y Chiang; Shanmugamurthy Lakshmanan; Ying-Ying Huang; Maria Garcia-Diaz; Mahdi Karimi; Alessandra Nara de Souza Rastelli; Rakkiyappan Chandran
Journal:  Nanotechnol Rev       Date:  2015-08-07       Impact factor: 7.848

4.  Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma.

Authors:  Pawel Mroz; Yumin Xia; Daisuke Asanuma; Aaron Konopko; Timur Zhiyentayev; Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Usman J Khan; Tim Wharton; Michael R Hamblin
Journal:  Nanomedicine       Date:  2011-05-19       Impact factor: 5.307

5.  Identification of amphetamine as a stimulant drug by pristine and doped C70 fullerenes: a DFT/TDDFT investigation.

Authors:  Elham Alipour; Shabnam Maleki; Negar Razavipour; Narjes Hajali; Seyedehdelaram Jahani
Journal:  J Mol Model       Date:  2021-05-15       Impact factor: 1.810

Review 6.  Anti-HIV-1 nanotherapeutics: promises and challenges for the future.

Authors:  Supriya D Mahajan; Ravikumar Aalinkeel; Wing-Cheung Law; Jessica L Reynolds; Bindukumar B Nair; Donald E Sykes; Ken-Tye Yong; Indrajit Roy; Paras N Prasad; Stanley A Schwartz
Journal:  Int J Nanomedicine       Date:  2012-10-05

7.  Adsorption of Cu(II) on oxidized multi-walled carbon nanotubes in the presence of hydroxylated and carboxylated fullerenes.

Authors:  Jing Wang; Zhan Li; Shicheng Li; Wei Qi; Peng Liu; Fuqiang Liu; Yuanlv Ye; Liansheng Wu; Lei Wang; Wangsuo Wu
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

Review 8.  Nanoparticle delivery system, highly active antiretroviral therapy, and testicular morphology: The role of stereology.

Authors:  Edwin Coleridge S Naidu; Samuel Oluwaseun Olojede; Sodiq Kolawole Lawal; Carmen Olivia Rennie; Onyemaechi Okpara Azu
Journal:  Pharmacol Res Perspect       Date:  2021-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.